Mealey's (April 16, 2018, 1:45 PM EDT) -- WASHINGTON, D.C. — In an April 13 holding, the Federal Circuit U.S. Court of Appeals upheld a Delaware federal judge’s determination that a patented method of treating schizophrenia patients with iloperidone, with a dosage based upon the patient’s genotype, is infringed by a proposed generic drug (Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Ltd., Nos. 2016-2707, -2708, Fed. Cir., 2018 U.S. App. LEXIS 9360)....